尼尔·欧文斯博士辞去医疗公司总裁兼首席运营官, 2026年5月31日生效. Dr. Neil Owens resigns as Medicure's President and COO, effective May 31, 2026.

医疗保健公司于2026年4月17日宣布,尼尔·欧文斯博士已辞去总裁和首席运营官职务,截至2026 年5 月31 日生效. Medicure Inc. announced on April 17, 2026, that Dr. Neil Owens has resigned as President and COO, effective by May 31, 2026. 首席执行官Albert D. Friesen博士将担任总裁, 以确保领导的连续性. CEO Dr. Albert D. Friesen will assume the President role to ensure leadership continuity. 该公司专注于制药和医疗保健产品的开发,通过其子公司销售AGGRASTAT®,并运营像Marley Drug这样的药房服务. The company focuses on developing pharmaceuticals and healthcare products, markets AGGRASTAT® through its subsidiary, and operates pharmacy services like Marley Drug.